WANY
CC icon

Wealthspire Advisors (New York)’s Chemours CC Stock Holding History

Wealthspire Advisors (New York)’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,011
Closed -$16K – 1325
2025
Q3 		$16K Buy
+1,011
New +$14.7K ﹤0.01% 1792

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wealthspire Advisors (New York)'s CC Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Chemours (CC) in Q4 2025, closing a stake of 1,011 shares — an estimated $16K sold.

Wealthspire Advisors (New York) first reported a position in CC in Q3 2025 and held it in 1 quarter. The position peaked at $16K in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,011 Chemours shares in Q4 2025, an estimated $16K.
  • Wealthspire Advisors (New York) first reported a position in Chemours in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Chemours position peaked at $16K in Q3 2025.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.